Bin, P., Huang, R., & Zhou, X
The glucagon-like peptide-1 receptor (GLP-1R) is ubiquitously present across multiple bodily tissues, including the pancreas, lungs, kidneys, central nervous system, cardiovascular system, gastrointestinal tract, as well as skin and vagus nerves (its tissue distribution is illustrated in Figure 2 ) (97)
Last Published 12.01.2025 Effective Date: 12.01.2025 This policy addresses the use of Evenity (romosozumab- aqqg) for the treatment of osteoporosis in postmenopausal patients at high risk for fracture
After studying data from non-clinical studies, clinical trials, post-marketing surveillance, and medical literature, the committee found that NAION is a very rare side effect of GLP-1
This can lead to issues like stomach pain, diarrhea, and weight gain
Nna VU, Usman UZ, Ofutet EO, Owu DU